Target intelligence / Profile preview

Glycosylphosphatidylinositol anchor attachment 1 pseudogene 2 (GPAA1P2)

Target
GPAA1P2
Molecular classification
Pseudogene
01

Overview

Glycosylphosphatidylinositol anchor attachment 1 pseudogene 2 (GPAA1P2) is a human pseudogene, which is a DNA sequence homologous to a functional gene (GPAA1) but contains disabling mutations preventing it from encoding a functional protein product[1][3][5]. By formal nomenclature, pseudogenes like GPAA1P2 are not expected to encode proteins and generally do not have direct biological activity[3][5]. There is no report of this pseudogene being a therapeutically relevant receptor, enzyme, transporter, or other classic drug target. While some pseudogenes have been implicated in regulation of gene expression or as potential non-coding RNAs affecting parental gene function, there is no such evidence for GPAA1P2 specifically[2][5]. It should not be considered a canonical therapeutic target for drug development. Pseudogenes may sometimes regulate their functional counterparts or be expressed as non-coding RNAs, but most are considered nonfunctional relics[2][4][5]. No evidence exists of protein or functional RNA derived from GPAA1P2, and it is not listed among genes associated with disease, biomarkers, or drug interaction[1][5]. Protein-coding GPAA1 (the parental gene) is involved in GPI-anchor biosynthesis, but GPAA1P2 itself lacks these functions, as indicated by its "pseudogene" annotation[1]. GPAA1P2 is a processed pseudogene, not a protein-coding gene, and does not function as a canonical target molecule such as a receptor, enzyme, or transporter[1][3][5].

Other names
GPAA1P2
02

Biological functions

No established functionLacks protein-coding potential
03

Disease associations

Not established

Beyond the preview

Go deeper on Glycosylphosphatidylinositol anchor attachment 1 pseudogene 2 (GPAA1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycosylphosphatidylinositol anchor attachment 1 pseudogene 2 (GPAA1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call